LOFIBRA
Dead / Cancelled — Cancelled — Section 8 (as of 07 Mar 2025)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 78250359
- Registration number
- 2878015
- Mark type
- Word mark
- Filed
- 15 May 2003
- Published for opposition
- 27 Jan 2004
- Registered
- 24 Aug 2004
- Next maintenance due
- 24 Aug 2014
- Attorney of record
- Alan L. Koller
Goods and services
- Class 005 — Pharmaceuticals: PRESCRIPTION PHARMACEUTICAL TO LOWER CHOLESTEROL
Owner
- RHODES PHARMACEUTICALS L.P., COVENTRY, RI, US
- RHODES PHARMACEUTICALS L.P., COVENTRY, RI, US
- TEVA CANADA LIMITED/TEVA CANADA LIMITEE, TORONTO, CA
- NOVOPHARM LIMITED, TORONTO, CA
- NOVOPHARM LIMITED, TORONTO, CA
- Teva Pharmaceuticals USA, Inc., North Wales, PA, US
- Teva Pharmaceuticals USA, Inc., North Wales, PA, US
Prior registrations
Prosecution history
- 07 Mar 2025 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 24 Aug 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 29 Jul 2020 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 15 May 2017 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 15 May 2017 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 07 Dec 2016 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 12 May 2014 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 12 May 2014 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 12 May 2014 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 29 Apr 2014 — REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
- 12 May 2014 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 Apr 2014 — TEAS SECTION 8 & 9 RECEIVED
- 29 Apr 2014 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Sept 2010 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 01 Sept 2010 — REGISTERED - SEC. 8 (6-YR) ACCEPTED